The UConn Health Institutional Biosafety Committee (IBC) is federally mandated to review work with recombinant or synthetic nucleic acids.
This committee meets monthly, usually on the second Thursday of the month. Exceptions are noted (*). Receive forms from and submit to email@example.com by the submission deadline.
NOTE: During the issues surrounding COVID-19, the UConn Health IBC will be open for business and functioning as normally as possible.
Upcoming meetings 2022:
|October 13||3:10 pm||WebEx||October 4|
|November 10||3:10 pm||WebEx||November 1|
|December 8||3:10 pm||WebEx||November 30|
|January 12, 2023||3:10 pm||WebEx||January 2, 2023|
|February 9, 2023||3:10 pm||WebEx||January 31, 2023|
|March 9, 2023||3:10 pm||WebEx||February 28, 2023|
If you are a person interested in or concerned about this type of research, you are invited to attend a meeting of the UCONN Health IBC. Meetings will be held virtually for the foreseeable future. Please contact an IBC representative for more information.
WCG Institutional Biosafety Committee Services periodically convenes open meetings regarding a human gene transfer study at UCONN Health. Announcements about these meetings will appear below when they are scheduled.